165 related articles for article (PubMed ID: 8220875)
1. Kinetics of rate-dependent slowing of intraventricular conduction by the class Ib antiarrhythmic agent tocainide in vivo.
Todt H; Zojer N; Raberger G
Br J Pharmacol; 1993 Sep; 110(1):145-50. PubMed ID: 8220875
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of the QT interval by dofetilide modulates rate-dependent effects of mexiletine on intraventricular conduction.
Todt H; Zojer N; Raberger G; Schütz W
Eur J Pharmacol; 1994 Nov; 265(1-2):43-52. PubMed ID: 7883028
[TBL] [Abstract][Full Text] [Related]
3. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
[TBL] [Abstract][Full Text] [Related]
4. Frequency-dependent effects of amitriptyline and maprotiline on conduction in the guinea pig His-Purkinje-system in vivo.
Todt H; Zojer N; Djamshidian-Tehrani S; Koppatz K; Krivanek P; Raberger G; Schütz W
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):670-6. PubMed ID: 7708124
[TBL] [Abstract][Full Text] [Related]
5. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
Valois M; Sasyniuk BI
Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
[TBL] [Abstract][Full Text] [Related]
6. Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization.
Mörtl D; Agneter E; Krivanek P; Koppatz K; Todt H
J Cardiovasc Pharmacol; 2003 Jun; 41(6):870-9. PubMed ID: 12775964
[TBL] [Abstract][Full Text] [Related]
7. Selective depression of conduction of premature action potentials in canine Purkinje fibres by class Ib antiarrhythmic drugs: comparison with Ia and Ic drugs.
Pallandi RT; Campbell TJ
Cardiovasc Res; 1988 Mar; 22(3):171-8. PubMed ID: 3167941
[TBL] [Abstract][Full Text] [Related]
8. Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
Timour Q; Aupetit JF; Loufoua-Moundanga J; Bertrix L; Freysz M; Faucon G
Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):338-44. PubMed ID: 2554155
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of use-dependent ventricular conduction slowing by antiarrhythmic drugs in humans.
Ranger S; Talajic M; Lemery R; Roy D; Villemaire C; Nattel S
Circulation; 1991 Jun; 83(6):1987-94. PubMed ID: 2040051
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
Kinnaird AA; Man RY
Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
[TBL] [Abstract][Full Text] [Related]
11. Clinical electrophysiology of intravenous sotalol, a beta-blocking drug with class III antiarrhythmic properties.
Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
Am Heart J; 1984 May; 107(5 Pt 1):888-95. PubMed ID: 6720518
[TBL] [Abstract][Full Text] [Related]
12. A quantitative analysis of use-dependent ventricular conduction slowing by procainamide in anesthetized dogs.
Villemaire C; Savard P; Talajic M; Nattel S
Circulation; 1992 Jun; 85(6):2255-66. PubMed ID: 1317275
[TBL] [Abstract][Full Text] [Related]
13. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
Kinnaird AA; Man RY
Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
[TBL] [Abstract][Full Text] [Related]
14. Retrograde gap in fast pathway conduction accentuated by the class I antiarrhythmic agent, flecainide.
Bexton RS; Hellestrand KJ; Nathan AW; Banim SO; Camm AJ
Pacing Clin Electrophysiol; 1983 Nov; 6(6):1273-7. PubMed ID: 6196737
[TBL] [Abstract][Full Text] [Related]
15. Modulating intraventricular conduction through competition of two class 1 antiarrhythmic agents: experience with ethacizin and lidocaine in canine heart.
Nesterenko VV; Anyukhovsky EP; Starmer CF; Beloshapko GG; Ivanovoch T; Makielski JC; Bugrij EM; Mazaev AV; Rosenshtraukh LV
J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():115-24. PubMed ID: 2038072
[TBL] [Abstract][Full Text] [Related]
16. Changes in atrioventricular conduction properties with refractory-period modulation.
Hewett KW; Le FK; Martin KL; Brasington CR; Piecuch S; Case CL
J Cardiovasc Pharmacol; 1996 Dec; 28(6):824-32. PubMed ID: 8961081
[TBL] [Abstract][Full Text] [Related]
17. Frequency dependent effects of tocainide, quinidine, and flecainide on conduction as reflected in the rise time of the monophasic action potential in the isolated guinea pig heart.
Duker BG
Cardiovasc Res; 1991 Mar; 25(3):217-22. PubMed ID: 1903081
[TBL] [Abstract][Full Text] [Related]
18. Effects of AWD 23-111, a new antiarrhythmic substance, on cardiac conduction and refractoriness.
Stark U; Stark G; Schwarzl I; Poppe H; Marx D; Decrinis M; Tritthart HA
Cardiovasc Drugs Ther; 1996 Nov; 10(5):531-8. PubMed ID: 8950067
[TBL] [Abstract][Full Text] [Related]
19. Effects of S-1389 (711389-S), a new antiarrhythmic agent, on the conduction in perfused guinea pig hearts.
Ninomiya M; Tani T; Ueda M
Jpn J Pharmacol; 1989 Dec; 51(4):555-62. PubMed ID: 2615048
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the rate-dependent effects of ethmozine on conduction, in vivo, and on the sodium current, in vitro, in the newborn heart.
Liu W; Clarkson CW; Yamasaki S; Chang C; Stolfi A; Pickoff AS
J Pharmacol Exp Ther; 1992 Nov; 263(2):608-16. PubMed ID: 1331407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
